Division of Clinical Pharmacology,Second Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou 310009,China
{{custom_zuoZheDiZhi}}
{{custom_authorNodes}}
{{custom_bio.content}}
{{custom_bio.content}}
{{custom_authorNodes}}
Collapse
History+
Received
Published
2007-06-29
2008-05-05
Issue Date
2008-05-05
Abstract
OBJECTIVE To study the pharmacokinetics and bioequivalence of flucloxacillin capsules in 20 Chinese healthy subjects.METHODS A single oral dose of 500 mg test or reference of flucloxacillin sodium capsules was given to each subject according to an open randomized crossover design.The concentrations of flucloxacillin in plasma were determined by HPLC method.The pharmacokinetic parameters were calculated and the bioequivalence was evaluated.RESULTS The concentration-time curves of flucloxacillin were fitted into a two-compartment model.The pharmacokinetic parameters of test and reference of flucloxacillin sodium capsules were as follows:tlag(0.1±0.2)and(0.2±0.1)h,tmax(0.8±0.2)and(0.9±0.3)h,ρmax(34.83±7.90)and(30.53 ±10.73)mg·L-1,Ka(4.869±2.135)and(3.682±1.681)h-1,t1/2(1.51±0.39)and(1.45±0.36)h,CL/F(9.268±2.165)and(9.876±2.657)L·h-1,Vd/F(23.58±11.26)and(22.34±12.35)L,AUC0-8 h(69.05±13.26)and(62.22±15.51)mg·h·L-1,AUC0-∞(70.55±13.47)and(63.69±15.69)mg·h·L-1.The relative bioavailability of the test formulation was(114.9±25.1)%.CONCLUSION The flucloxacillin sodium capsules had a rapid absorption and elimination profile in Chinese volunteers.The two flucloxacillin formulations were bioequivalent.
RUN Zou-rong;ZHOU Qun;YUN Hong;JING o;XU Dong-hng;LOU Hong-gng.
Pharmacokinetics and Bioequivalence of Flucloxacillin Capsules in Chinese Healthy Subjects [J]. Chinese Pharmaceutical Journal, 2008, 43(09): 699-701
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] LAN H,JIANG S.The clinical efficacy and safety evaluation of flucloxacillin capsule[J] .Chin J Antibiot(中国抗生素杂志),1999,24(5):350-352.
[2] WANG J,HOU J,HAO F L,et al. The clinical safety evaluation on flucloxicillin capsule of 1021 cases[J] .Chin J Antibiot(中国抗生素杂志),2001,26(6):457-463.
[3] HOU J,WANG J,ZHANG Y L,et al. Randomized controlled clinical evaluation of flucloxacillin capsules in treatment of 121 cases of bacterial infections[J] .Chin J Infect Chemother(中国抗感染化疗杂志),2003,3(5):294-296.
[4] RODER B L,FRIMODT-MOLLER N,ESPERSEN F,et al. Dicloxacillin and flucloxacillin: pharmacokinetics,protein binding and serum bactericidal titers in healthy subjects after oral administration[J] .Infection,1995,23(2):107-112.
[5] GATH J,CHARLES B,SAMPSON J,et al. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients[J] .J Clin Pharmacol,1995,35(1):31-36.